PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

Cited by (1,079)

Items 701–800 of 1,079

1. TIGIT: a novel immunotherapy target moving from bench to bedside
   Benjamin Lev Solomon, Ignacio Garrido‐Laguna · 2018 · Cancer Immunology Immunotherapy
2. Liquid biopsy in the era of immuno-oncology: is it ready for prime-time use for cancer patients?
   Paul M Hofman, Simon Heeke, Catherine Alix‐Panabières, Klaus Pantel · 2019 · Annals of Oncology
3. Cancer immunotherapy resistance based on immune checkpoints inhibitors: Targets, biomarkers, and remedies
   Elísabeth Pérez-Ruiz, Ignacio Melero, Joanna Kopecka, Ana Bela Sarmento‐Ribeiro, Marilina García‐Aranda, Javier De Las Rivas · 2020 · Drug Resistance Updates
4. <scp>UV</scp>‐induced somatic mutations elicit a functional T cell response in the <scp>YUMMER</scp>1.7 mouse melanoma model
   Wang, Jake, Perry, Curtis J., Meeth, Katrina, Thakral, Durga, Damsky, William, Micevic, Goran, Kaech, Susan, Blenman, Kim, Bosenberg, Marcus · 2017 · Pigment Cell &amp; Melanoma Research
5. PD-L1 promotes colorectal cancer stem cell expansion by activating HMGA1-dependent signaling pathways
   Wei Fang, Tong Zhang, Shu-Chou Deng, Jianchang Wei, Ping Yang, Qiang Wang, Zhuanpeng Chen, Wanglin Li, Huacui Chen, He Hu et al. · 2019 · Cancer Letters
6. Review of PD-1/PD-L1 Inhibitors in Metastatic dMMR/MSI-H Colorectal Cancer
   A. Oliveira, Luís Bretes, Irene Furtado · 2019 · Frontiers in Oncology
7. Key changes to the World Health Organization (WHO) classification of female genital tumours introduced in the 5th edition (2020)
   Wilson Glenn McCluggage, Naveena Singh, C. Blake Gilks · 2022 · Histopathology
8. Identification of germline genetic mutations in patients with pancreatic cancer
   Erin E. Salo‐Mullen, Eileen Mary O'Reilly, David Paul Kelsen, Asad M. Ashraf, Maeve Aine Lowery, Kenneth H. Yu, Diane L. Reidy‐Lagunes, Andrew S. Epstein, Anne Lincoln, Amethyst Saldia et al. · 2015 · Cancer
9. A First-in-Human Phase I Study of Subcutaneous Outpatient Recombinant Human IL15 (rhIL15) in Adults with Advanced Solid Tumors
   Jeffrey S. Miller, Chihiro Morishima, Douglas G. McNeel, Manish Ramesh Patel, Holbrook E K Kohrt, John A. Thompson, Paul M. Sondel, Heather A. Wakelee, Mary Lenora Disis, Judith C. Kaiser et al. · 2017 · Clinical Cancer Research
10. Molecular and histopathology directed therapy for advanced bladder cancer
    Constantine Alifrangis, Ursula McGovern, Alex Freeman, Thomas B. Powles, Mark David Linch · 2019 · Nature Reviews Urology
11. What is New in the 2019 World Health Organization (WHO) Classification of Tumors of the Digestive System: Review of Selected Updates on Neuroendocrine Neoplasms, Appendiceal Tumors, and Molecular Testing
    Naziheh Assarzadegan, Elizabeth Anne Montgomery · 2020 · Archives of Pathology & Laboratory Medicine
12. Metabolism in tumor microenvironment: Implications for cancer immunotherapy
    Rongchen Shi, Yi‐Quan Tang, Hongming Miao · 2020 · MedComm
13. Programmed cell death protein 1 inhibitor treatment is associated with acute kidney injury and hypocalcemia: meta-analysis
    Sandhya Manohar, Panagiotis Kompotiatis, Charat Thongprayoon, Wisit Cheungpasitporn, Joerg Herrmann, Sandra M. Herrmann · 2018 · Nephrology Dialysis Transplantation
14. Functional systemic CD4 immunity is required for clinical responses to PD‐L1/PD‐1 blockade therapy
    Miren Zuazo, Hugo Arasanz, G. Fernández-Hinojal, María Jesús García-Granda, María Gato, Ana Bocanegra, Berta Hernández, Maite Martínez, Lucía Teijeira, Idoia Morilla et al. · 2019 · EMBO Molecular Medicine
15. Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors
    Sanjeevani Arora, Rodion A. Velichinskii, Randy W. Lesh, Usman Ali, Michal Jakub Kubiak, Pranshu Bansal, Hossein Borghaei, Martin Joseph Edelman, Yanis Boumber · 2019 · Advances in Therapy
16. Human Anti-tumor Immunity: Insights from Immunotherapy Clinical Trials
    Jackson G. Egen, Wenjun Ouyang, Lawren C. Wu · 2020 · Immunity
17. Tumor-Infiltrating Lymphocytes in Colorectal Cancer: The Fundamental Indication and Application on Immunotherapy
    Ziyi Bai, Yao Zhou, Zifan Ye, Jialong Xiong, Hongying Lan, Feng Wang · 2022 · Frontiers in Immunology
18. Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option
    Maartje W. Rohaan, Joost H. van den Berg, Pia Kvistborg, John B.A.G. Haanen · 2018 · Journal for ImmunoTherapy of Cancer
19. The impact of PD-L1 N-linked glycosylation on cancer therapy and clinical diagnosis
    Ying‐Nai Wang, Heng‐Huan Lee, Jennifer L. Hsu, Dihua Yu, Mien‐Chie Hung · 2020 · Journal of Biomedical Science
20. Tumour predisposition and cancer syndromes as models to study gene–environment interactions
    Michele Carbone, Sarah T. Arron, Bruce Beutler, Angela Bononi, Webster K. Cavenee, James E. Cleaver, Carlo Maria Croce, Alan D. D’Andrea, William D. Foulkes, Giovanni Gaudino et al. · 2020 · Nature reviews. Cancer
21. Immune Checkpoint Inhibition in Hepatocellular Carcinoma: Basics and Ongoing Clinical Trials
    Masatoshi Kudo · 2017 · Oncology
22. Rationale and Design of the Targeted Agent and Profiling Utilization Registry Study
    Pam K. Mangat, Susan Halabi, Suanna S. Bruinooge, Elizabeth S. Garrett-Mayer, Ajjai Shivaram Alva, Katherine A. Janeway, Philip J. Stella, Emile E. Voest, Kathleen J. Yost, Jane Perlmutter et al. · 2018 · JCO Precision Oncology
23. Future prospects of immune checkpoint blockade in cancer: from response prediction to overcoming resistance
    Young‐Jun Park, Da‐Sol Kuen, Yeonseok Chung · 2018 · Experimental & Molecular Medicine
24. Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy
    Nicole A. P. Lieberman, Kole DeGolier, Heather M Kovar, Amira D Davis, Virginia J. Hoglund, Jeffrey Stevens, Conrad Winter, Gail H. Deutsch, Scott N. Furlan, Nicholas Alexander Vitanza et al. · 2018 · Neuro-Oncology
25. Trapping of Lipopolysaccharide to Promote Immunotherapy against Colorectal Cancer and Attenuate Liver Metastasis
    Wantong Song, Karthik Tiruthani, Ying Wang, Limei Shen, Mengying Hu, Oleksandra Dorosheva, Kunyu Qiu, Karina Kinghorn, Rihe Liu, Leaf Huang · 2018 · Advanced Materials
26. Immune dysregulation in cancer patients developing immune-related adverse events
    Shaheen Khan, Saad A. Khan, Xin Luo, Farjana Jahan Fattah, Jessica M. Saltarski, Yvonne Gloria-McCutchen, Rong Lü, Yang Xie, Quan Li, Edward K. Wakeland et al. · 2018 · British Journal of Cancer
27. Tumor infiltrating lymphocytes (TIL) therapy in metastatic melanoma: boosting of neoantigen-specific T cell reactivity and long-term follow-up
    Joost H. van den Berg, Bianca Heemskerk, Nienke van Rooij, Raquel Gomez-Eerland, Samira Michels, Maaike van Zon, Renate de Boer, Noor A. M. Bakker, Annelies Jorritsma‐Smit, Marit M. van Buuren et al. · 2020 · Journal for ImmunoTherapy of Cancer
28. Predictive biomarkers of response for immune checkpoint inhibitors in non–small-cell lung cancer
    Arsela Prelaj, Rebecca Yin Tay, Roberto Ferrara, Nathalie Chaput, Benjamin Besse, Raffaele Califano · 2018 · European Journal of Cancer
29. Survival improvement for patients with metastatic colorectal cancer over twenty years
    Zeineddine, Fadl A., Zeineddine, Mohammad A., Yousef, Abdelrahman, Gu, Yue, Chowdhury, Saikat, Dasari, Arvind, Huey, Ryan W., Johnson, Benny, Kee, Bryan, Lee, Michael S. et al. · 2023 · npj Precision Oncology
30. Endometrial Carcinomas with POLE Exonuclease Domain Mutations Have a Favorable Prognosis
    Melissa K. McConechy, Aline Talhouk, Samuel C. Y. Leung, Derek S. Chiu, Winnie Yang, Janine Senz, Linda J. Reha-Krantz, Cheng‐Han Lee, David D. Huntsman, C. Blake Gilks et al. · 2016 · Clinical Cancer Research
31. The therapeutic significance of mutational signatures from DNA repair deficiency in cancer
    Jennifer Ma, Jeremy S. Setton, Nancy Y. Lee, Nadeem Riaz, Simon N. Powell · 2018 · Nature Communications
32. Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial
    Feng Wang, Ying Jin, Min Wang, Hui Luo, Weijia Jia Fang, Yingnan Wang, Yan‐Xing Chen, Run-jie Huang, Wen‐Long Guan, Jibin Li et al. · 2024 · Nature Medicine
33. Tumor Evolution as a Therapeutic Target
    Nabil Amirouchene-Angelozzi, Charles Swanton, Alberto Bardelli · 2017 · Cancer Discovery
34. Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017
    Veda N. Giri, Karen E. Knudsen, William Kevin Kelly, Wassim M. Abida, Gerald L. Andriole, Chris H. Bangma, Justin E. Bekelman, Mitchell C. Benson, Amie M Blanco, Arthur L. “Bud” Burnett et al. · 2017 · Journal of Clinical Oncology
35. Multidisciplinary approach of liver metastases from colorectal cancer
    René A. Adam, Yuki Kitano · 2019 · Annals of Gastroenterological Surgery
36. Molecular approaches for classifying endometrial carcinoma
    Josep Maria Piulats, Esther Guerra, Marta Gil-Martín, Berta Roman‐Canal, Sónia Gatius, Rebeca Sanz Pamplona, Ana Velasco, August Vidal, Xavier Matías‐Guiu · 2016 · Gynecologic Oncology
37. Melanoma: What do all the mutations mean?
    Elizabeth J. Davis, Douglas Buckner Johnson, Jeffrey Alan Sosman, Sunandana Chandra · 2018 · Cancer
38. Mismatch Repair and Colon Cancer: Mechanisms and Therapies Explored
    Stephen K. H. Li, Alberto Martín · 2016 · Trends in Molecular Medicine
39. Molecular subtyping of colorectal cancer: Recent progress, new challenges and emerging opportunities
    Wei Wang, Raju Kandimalla, Hao Huang, Lina Zhu, Ying Li, Feng Gao, Ajay Goel, Xin Wang · 2018 · Seminars in Cancer Biology
40. Metabolism‐associated molecular classification of hepatocellular carcinoma
    Chen Guang Yang, Xiaowen Huang, Zhicheng Liu, Wenxin Qin, Cun Wang · 2020 · Molecular Oncology
41. Beta2-microglobulin(B2M) in cancer immunotherapies: Biological function, resistance and remedy
    Hanbing Wang, Baorui Liu, Jia Wei · 2021 · Cancer Letters
42. Neoantigen-targeted CD8+ T cell responses with PD-1 blockade therapy
    Cristina Puig-Saus, Barbara Sennino, Songming Peng, Clifford L. Wang, Zheng Pan, Benjamin Yuen, Bhamini Purandare, Duo An, Boi Bryant Quach, Diana Nguyen et al. · 2023 · Nature
43. The Role of the Tumor Vasculature in the Host Immune Response: Implications for Therapeutic Strategies Targeting the Tumor Microenvironment
    Hendry, Shona A., Farnsworth, Rae H., Solomon, Benjamin, Achen, Marc G., Stacker, Steven A., Fox, Stephen B. · 2016 · Frontiers in Immunology
44. Biomarkers for immunotherapy in bladder cancer: a moving target
    David Henry Aggen, Charles G. Drake · 2017 · Journal for ImmunoTherapy of Cancer
45. Correlate tumor mutation burden with immune signatures in human cancers
    Xiaosheng Wang, Mengyuan Li · 2019 · BMC Immunology
46. Biomarkers of response to PD-1 pathway blockade
    Hanxiao Li, P. Anton van der Merwe, Shivan Sivakumar · 2022 · British Journal of Cancer
47. Radiation therapy and PD-1/PD-L1 blockade: the clinical development of an evolving anticancer combination
    Jun Gong, Thang Q. Le, Erminia Massarelli, Andrew Eugene Hendifar, Richard Tuli · 2018 · Journal for ImmunoTherapy of Cancer
48. Patterns and prognostic relevance of PD-1 and PD-L1 expression in colorectal carcinoma
    Lee, Lik Hang, Cavalcanti, Marcela S, Segal, Neil H, Hechtman, Jaclyn F, Weiser, Martin R, Smith, J Joshua, Garcia-Aguilar, Julio, Sadot, Eran, Ntiamoah, Peter, Markowitz, Arnold J et al. · 2016 · Modern Pathology
49. The Pancreatic Cancer Microenvironment
    Stephanie K. Dougan · 2017 · The Cancer Journal
50. Recent progress in Lynch syndrome and other familial colorectal cancer syndromes
    Patrick McKay Boland, Matthew B.B. Yurgelun, Clement Richard Boland · 2018 · CA A Cancer Journal for Clinicians
51. A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers
    Scott N. Gettinger, Jungmin Choi, Nikita Lavanya Mani, Miguel F. Sanmamed, Ila J. Datar, Ryan Sowell, Victor Y. Du, Edward J. Kaftan, Sarah B. Goldberg, Weilai Dong et al. · 2018 · Nature Communications
52. Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors
    Fizazi, Karim, Drake, Charles G., Beer, Tomasz M., Kwon, Eugene D., Scher, Howard I., Gerritsen, Winald R., Bossi, Alberto, den Eertwegh, Alfons J.M. van, Krainer, Michael, Houede, Nadine et al. · 2020 · European Urology
53. Lymphocyte‐activation gene‐3, an important immune checkpoint in cancer
    Yayi He, Christopher J. Rivard, Leslie M. Rozeboom, Hui Yu, Kim E. Ellison, Ashley A. Kowalewski, Caicun Zhou, Fred R. Hirsch · 2016 · Cancer Science
54. Microsatellite Instability: Diagnosis, Heterogeneity, Discordance, and Clinical Impact in Colorectal Cancer
    Camille Evrard, Gaëlle Tachon, Violaine Randrian, Lucie Karayan, David Tougeron · 2019 · Cancers
55. Endometrial cancer: Not your grandmother's cancer
    Jessica Nell McAlpine, Sarah Madhu Temkin, Helen J MacKay · 2016 · Cancer
56. Immunotherapy for Colorectal Cancer: A Review of Current and Novel Therapeutic Approaches
    Aaron J Franke, William Paul Skelton, Jason Scott Starr, Hiral D. Parekh, James J. Lee, Michael James Overman, Carmen Joseph Allegra, Thomas J. George · 2019 · JNCI Journal of the National Cancer Institute
57. Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institution
    Vaia Florou, Andrew Eric Rosenberg, Eric Wieder, Krishna V. Komanduri, Despina S. Kolonias, Mohamed Uduman, John C. Castle, Jennifer S. Buell, Jonathan C. Trent, Breelyn Ann Wilky · 2019 · Journal for ImmunoTherapy of Cancer
58. Cetuximab Rechallenge Plus Avelumab in Pretreated Patients With RAS Wild-type Metastatic Colorectal Cancer
    Erika Martinelli, Giulia Martini, Vincenzo Famiglietti, Teresa Troiani, Stefania Napolitano, Filippo Pietrantonio, Davide Ciardiello, Marinella Terminiello, Carola Borrelli, Pietro Paolo Vitiello et al. · 2021 · JAMA Oncology
59. Human lung cancer harbors spatially organized stem-immunity hubs associated with response to immunotherapy
    Jonathan H. Chen, Linda T. Nieman, Maxwell Spurrell, Vjola Jorgji, Liad Elmelech, Peter M. Richieri, Katherine H. Xu, Roopa Madhu, Milan Parikh, Izabella Zamora et al. · 2024 · Nature Immunology
60. NCCN Guidelines Updates: Management of Metastatic Colorectal Cancer.
    Wells A. Messersmith · 2019 · PubMed
61. Tumor Mutational Burden and PTEN Alterations as Molecular Correlates of Response to PD-1/L1 Blockade in Metastatic Triple-Negative Breast Cancer
    Romualdo Barroso‐Sousa, Tanya Elizabeth Keenan, Sònia Pernas, Pedro Exman, Esha Jain, Ana Christina Garrido-Castro, Melissa E. Hughes, Brittany Bychkovsky, Renato Umeton, Janet L. Files et al. · 2020 · Clinical Cancer Research
62. Colorectal Cancer Disparity in African Americans
    Gaius J. Augustus, Nathan A. Ellis · 2017 · American Journal Of Pathology
63. The Reciprocity between Radiotherapy and Cancer Immunotherapy
    Yifan Wang, Zhi-Gang Liu, Hengfeng Yuan, Weiye Deng, Jing Li, Yu-Hui Huang, Betty Y.S. Kim, Michael D. Story, Wen Jiang · 2018 · Clinical Cancer Research
64. Preoperative Chemoradiotherapy plus Nivolumab before Surgery in Patients with Microsatellite Stable and Microsatellite Instability–High Locally Advanced Rectal Cancer
    Hideaki Bando, Yuichiro Tsukada, Koji Inamori, Yosuke Togashi, Shohei Koyama, Daisuke Kotani, Shota Fukuoka, Satoshi Yuki, Yoshito Komatsu, Shigenori Homma et al. · 2022 · Clinical Cancer Research
65. Microsatellite Instability in Patients With Stage III Colon Cancer Receiving Fluoropyrimidine With or Without Oxaliplatin: An ACCENT Pooled Analysis of 12 Adjuvant Trials
    Romain Cohen, Julien Taı̈eb, Jack Fiskum, Greg Yothers, Richard M. Goldberg, Takayuki Yoshino, Steven R. Alberts, Carmen Joseph Allegra, Aimery de Gramont, J. F. Seitz et al. · 2020 · Journal of Clinical Oncology
66. Endogenous retrovirus expression is associated with response to immune checkpoint blockade in clear cell renal cell carcinoma
    Panda, Anshuman, de Cubas, Aguirre A., Stein, Mark, Riedlinger, Gregory, Kra, Joshua, Mayer, Tina, Smith, Christof C., Vincent, Benjamin G., Serody, Jonathan S., Beckermann, Kathryn E. et al. · 2018 · JCI Insight
67. Somatic and germline genomics in paediatric acute lymphoblastic leukaemia
    Ching‐Hon Pui, Kim E. Nichols, Jun J.J. Yang · 2018 · Nature Reviews Clinical Oncology
68. Current issues and perspectives in PD-1 blockade cancer immunotherapy
    Kenji Chamoto, Ryusuke Hatae, Tasuku Honjo · 2020 · International Journal of Clinical Oncology
69. SBRT combined with PD-1/PD-L1 inhibitors in NSCLC treatment: a focus on the mechanisms, advances, and future challenges
    Yu Chen, Min Gao, Zhaoqin Huang, Jinming Yu, Xiangjiao Meng · 2020 · Journal of Hematology & Oncology
70. Assessment of programmed death-ligand 1 expression and tumor-associated immune cells in pediatric cancer tissues
    Majzner, Robbie G., Simon, Jason S., Grosso, Joseph F., Martinez, Daniel, Pawel, Bruce R., Santi, Mariarita, Merchant, Melinda S., Geoerger, Birgit, Hezam, Imene, Marty, Virginie et al. · 2017 · Cancer
71. PD-L1 expression in perihilar and intrahepatic cholangiocarcinoma
    Jacqueline Fontugne, Jérémy Augustin, Anaïs Pujals, Philippe Compagnon, Benoı̂t Rousseau, Alain Luciani, Christophe Tournigand, Daniel Cherqui, Daniel Azoulay, Jean–Michel Pawlotsky et al. · 2017 · Oncotarget
72. Multispectral imaging for quantitative and compartment‐specific immune infiltrates reveals distinct immune profiles that classify lung cancer patients
    Artur Mezheyeuski, Christian Holst Bergsland, Max Backman, Dijana Djureinovic, Tobias Sjöblom, Jarle Bruun, Patrick Micke · 2017 · The Journal of Pathology
73. Phase II Study of Pembrolizumab As First-Line, Single-Drug Therapy for Patients With Unresectable Cutaneous Squamous Cell Carcinomas
    E. Maubec, Marouane Boubaya, Peter K. Petrow, Marie Beylot-Barry, Nicole Basset‐Séguin, Lydia Deschamps, Jean‐Jacques Grob, Brigitte Dréno, Isabelle Scheer-Senyarich, Coralie Bloch‐Queyrat et al. · 2020 · Journal of Clinical Oncology
74. The impact of tumor profiling approaches and genomic data strategies for cancer precision medicine
    Andrea Garofalo, Lynette Marie Sholl, Brendan Michael Reardon, Amaro N Taylor-Weiner, Ali Amin‐Mansour, Diana Miao, David Liu, Nelly M. Oliver, Laura E. MacConaill, Matthew D. Ducar et al. · 2016 · Genome Medicine
75. Medical management of gastric cancer: a 2017 update
    Nikolaos Charalampakis, Panagiota Economopoulou, Ioannis Kotsantis, Maria Tolia, Dimitriοs Schizas, Theodore Liakakos, Elena C. Elimova, Jaffer A. Ajani, Amanda K. Psyrri · 2017 · Cancer Medicine
76. Updates on immunotherapy for colorectal cancer
    Aparna Kalyan, Sheetal Mehta Kircher, Hiral Anil Shah, Mary F. Mulcahy, Al B. Benson · 2018 · Journal of Gastrointestinal Oncology
77. Distinct mutational signatures characterize concurrent loss of polymerase proofreading and mismatch repair
    Nicholas J. Haradhvala, Jaegil Kim, Yosef E. Maruvka, Paz P Polak, Daniel Rosebrock, Dimitri G. Livitz, Julian M. Hess, Ignaty Leshchiner, Atanas Kamburov, Kent William Mouw et al. · 2018 · Nature Communications
78. Next generation sequencing‐based gene panel tests for the management of solid tumors
    Masayuki Nagahashi, Yoshifumi Shimada, Hiroshi Ichikawa, Hitoshi Kameyama, Kazuaki Takabe, Shujiro Okuda, Toshifumi Wakai · 2018 · Cancer Science
79. Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts
    Anna Capasso, Julie Lang, Todd M. Pitts, Kimberly Rae Jordan, Christopher Hanyoung Lieu, S. Lindsey Davis, Jennifer Robinson Diamond, Scott Kopetz, Jacob Barbee, Jacob N. Peterson et al. · 2019 · Journal for ImmunoTherapy of Cancer
80. Microsatellite instability and immune checkpoint inhibitors: toward precision medicine against gastrointestinal and hepatobiliary cancers
    Yuji Eso, Takahiro Shimizu, Haruhiko Takeda, Atsushi Takai, Hiroyuki Marusawa · 2019 · Journal of Gastroenterology
81. Endocrine side effects of cancer immunotherapy
    Cukier, Priscilla, Santini, Fernando C, Scaranti, Mariana, Hoff, Ana O · 2017 · Endocrine-Related Cancer
82. Genomic Approaches to Understanding Response and Resistance to Immunotherapy
    David A. Braun, Kelly P. Burke, Eliezer M. Van Allen · 2016 · Clinical Cancer Research
83. Colorectal mixed adenoneuroendocrine carcinomas and neuroendocrine carcinomas are genetically closely related to colorectal adenocarcinomas
    Moritz Jesinghaus, Björn Konukiewitz, Gisela Keller, Matthias Kloor, Katja Steiger, Magdalena Reiche, Roland Penzel, Volker Endris, Ruža Arsenić, Gratiana Hermann et al. · 2017 · Modern Pathology
84. Consensus molecular subtypes of colorectal cancer are recapitulated in in vitro and in vivo models
    Janneke F. Linnekamp, Sander R. van Hooff, Pramudita R. Prasetyanti, Raju Kandimalla, Joyce Y. Buikhuisen, Evelyn Fessler, Prashanthi Ramesh, Kelly A. S. T. Lee, Grehor G. W. Bochove, Johan H. de Jong et al. · 2018 · Cell Death and Differentiation
85. Sex Differences in Cancer Immunotherapy Efficacy, Biomarkers, and Therapeutic Strategy
    Shixiang Wang, Li An Cowley, Xuesong Liu · 2019 · Molecules
86. Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy
    Fumet, Jean-David, Richard, Corentin, Ledys, Fanny, Klopfenstein, Quentin, Joubert, Philippe, Routy, Bertrand, Truntzer, Caroline, Gagné, Andréanne, Hamel, Marc-André, Guimaraes, Camila Figueiredo et al. · 2018 · British Journal of Cancer
87. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer
    John M. Carethers · 2015 · World Journal of Gastroenterology
88. The role of neoantigens in response to immune checkpoint blockade
    Nadeem Riaz, Luc G.T. Morris, Jonathan J. Havel, Vladimir Makarov, Alexis Desrichard, Timothy An-thy Chan · 2016 · International Immunology
89. Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology
    Antonia R. Sepulveda, Stanley R. Hamilton, Carmen Joseph Allegra, Wayne W. Grody, Allison M. Cushman‐Vokoun, William K. Funkhouser, Scott Kopetz, Christopher Hanyoung Lieu, Noralane M. Lindor, Bruce D. Minsky et al. · 2017 · Archives of Pathology & Laboratory Medicine
90. Colorectal Cancers: An Update on Their Molecular Pathology
    Kentaro Inamura · 2018 · Cancers
91. Inflammation and Colorectal Cancer
    Apple Long, Emma T. Lundsmith, Kathryn E. Hamilton · 2017 · Current Colorectal Cancer Reports
92. Multidimensional, quantitative assessment of PD-1/PD-L1 expression in patients with Merkel cell carcinoma and association with response to pembrolizumab
    Nicolás A. Giraldo, Peter L. Nguyen, Elizabeth L. Engle, Genevieve J. Kaunitz, Tricia R. Cottrell, Sneha Berry, Benjamin Green, Abha Soni, Jonathan D. Cuda, Julie E. Stein et al. · 2018 · Journal for ImmunoTherapy of Cancer
93. The DNA Damaging Revolution: PARP Inhibitors and Beyond
    Timothy Anthony Yap, Ruth Plummer, Nilofer Saba Azad, Thomas Helleday · 2019 · American Society of Clinical Oncology Educational Book
94. Tumour mutational burden: clinical utility, challenges and emerging improvements
    Jan Budczies, Daniel N. Kazdal, Michael Menzel, Susanne Beck, Klaus Kluck, Christian Altbürger, Constantin Schwab, Michael Allgäuer, Aysel Ahadova, Matthias Kloor et al. · 2024 · Nature Reviews Clinical Oncology
95. Phase Ib study of atezolizumab combined with cobimetinib in patients with solid tumors.
    Hellmann, M.D., Kim, T.-W., Lee, C.B., Goh, B.-C., Miller, W.H., Oh, D.-Y., Jamal, R., Chee, C.-E., Chow, L.Q.M., Gainor, J.F. et al. · 2019 · Annals of Oncology
96. Assessment of Tumor Sequencing as a Replacement for Lynch Syndrome Screening and Current Molecular Tests for Patients With Colorectal Cancer
    Heather Hampel, Rachel Pearlman, Mallory Beightol, Weiqiang Zhao, Daniel R. Jones, Wendy L. Frankel, Paul J. Goodfellow, Ahmet Uğur Yılmaz, Kristin Miller, Jason Bacher et al. · 2018 · JAMA Oncology
97. Gut Microbiome Influences the Efficacy of PD-1 Antibody Immunotherapy on MSS-Type Colorectal Cancer via Metabolic Pathway
    Xu, Xinjian, Lv, Ji, Guo, Fang, Li, Jing, Jia, Yitao, Jiang, Da, Wang, Na, Zhang, Chao, Kong, Lingyu, Liu, Yabin et al. · 2020 · Frontiers in Microbiology
98. Inhibitors of the PD-1 Pathway in Tumor Therapy
    Martin W. LaFleur, Yuki Muroyama, Charles G. Drake, Arlene H. Sharpe · 2018 · The Journal of Immunology
99. The Developing Story of Predictive Biomarkers in Colorectal Cancer
    Stergios Boussios, Mehmet Akif Öztürk, Michele Moschetta, Afroditi Karathanasi, Nikolaos Zakynthinakis-Kyriakou, Konstantinos H. Katsanos, Dimitrios K. Christodoulou, Nicholas A. Pavlidis · 2019 · Journal of Personalized Medicine
100. Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors
     Elise M. Fiala, Gowtham Jayakumaran, Audrey Mauguen, Jennifer A. Kennedy, Nancy Bouvier, Yelena M. Kemel, Megan Harlan Fleischut, Anna Maio, Erin E. Salo‐Mullen, Margaret R. Sheehan et al. · 2021 · Nature Cancer